BC
BIT Capital Portfolio holdings
AUM
$2.19B
1-Year Est. Return
149.53%
1 Year Est. Return
+149.53%
AUM
$1.53B
AUM Growth
+$704M
(+85%)
Holding
107
Top Buys
| 1 | +$103M | |
| 2 | +$66.6M | |
| 3 | +$59.9M | |
| 4 |
Amazon
AMZN
|
+$47.8M |
| 5 |
Advanced Micro Devices
AMD
|
+$43.7M |
Top Sells
| 1 | +$76.3M | |
| 2 | +$50.2M | |
| 3 | +$44.8M | |
| 4 |
BridgeBio Pharma
BBIO
|
+$23.3M |
| 5 |
Robinhood
HOOD
|
+$20.7M |
Sector Composition
| 1 | Financials | 39.09% |
| 2 | Technology | 32.72% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Healthcare | 9.64% |
| 5 | Communication Services | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
BridgeBio Pharma
BBIO
$12.5B
| $758K | 0.04% |
17,560
-540,086
|
|
||
52
Uber
UBER
$191B
| $678K | 0.04% |
7,264
+3,205
|
|
||
53
Airbnb
ABNB
$73.5B
| $562K | 0.03% |
4,247
+415
|
|
||
54
Alibaba
BABA
$381B
| $539K | 0.03% |
+4,750
|
|
||
55
Zoom
ZM
$25.2B
| $485K | 0.03% |
+6,219
|
|
||
56
Nu Holdings
NU
$75.3B
| $463K | 0.03% |
33,740
+942
|
|
||
57
Applied Materials
AMAT
$178B
| $418K | 0.02% |
2,282
-338
|
|
||
58
Intuitive Surgical
ISRG
$200B
| $408K | 0.02% |
750
+421
|
|
||
59
Braze
BRZE
$3.14B
| $382K | 0.02% |
+13,595
|
|
||
60
UnitedHealth
UNH
$301B
| $367K | 0.02% |
1,177
+318
|
|
||
61
EVgo
EVGO
$404M
| $360K | 0.02% |
98,660
+76,344
|
|
||
|
GTM
62
ZoomInfo Technologies
GTM
$3.18B
| $290K | 0.02% |
28,668
+2,005
|
|
||
|
BPMC
63
DELISTED
Blueprint Medicines
BPMC
| $182K | 0.01% |
1,423
-76,379
|
|
||
64
Scholar Rock
SRRK
$2.89B
| $152K | 0.01% |
4,278
-38,416
|
|
||
65
IDEAYA Biosciences
IDYA
$2.79B
| $88.7K | 0.01% |
4,220
-38,495
|
|
||
66
argenx
ARGX
$54.9B
| $87.1K | 0.01% |
158
-1,689
|
|
||
67
Ultragenyx Pharmaceutical
RARE
$3.17B
| $74.7K | ﹤0.01% |
2,055
-19,600
|
|
||
68
Agios Pharmaceuticals
AGIO
$2.48B
| $74.2K | ﹤0.01% |
2,230
-19,238
|
|
||
69
Revolution Medicines
RVMD
$12.4B
| $71.9K | ﹤0.01% |
1,955
-3,089
|
|
||
70
Immunocore
IMCR
$1.79B
| $68.3K | ﹤0.01% |
2,176
-38,611
|
|
||
71
Akero Therapeutics
AKRO
$4.46B
| $67.3K | ﹤0.01% |
1,261
-3,176
|
|
||
72
Enliven Therapeutics
ELVN
$1.2B
| $63.8K | ﹤0.01% |
3,181
-16,205
|
|
||
73
Beam Therapeutics
BEAM
$2.2B
| $61.3K | ﹤0.01% |
3,603
-12,168
|
|
||
74
AnaptysBio
ANAB
$921M
| $60.1K | ﹤0.01% |
2,706
-22,716
|
|
||
75
Day One Biopharmaceuticals
DAWN
$909M
| $54.7K | ﹤0.01% |
8,413
-108,152
|
|